Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● With a P/E ratio at 12.15 for the current year and 11.23 for next year, earnings multiples are highly attractive compared with competitors.

● The company shows low valuation levels, with an enterprise value at 0.4 times its sales.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.


Weaknesses

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● The company does not generate enough profits, which is an alarming weak point.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.